Education
About Us
Working with TipRanks
Follow Us
Aptorum Group Ltd (APM)
NASDAQ:APM
APM Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.46 - $7.49
Previous CloseN/A
Volume172.64K
Average Volume (3M)14.02M
Market Cap
$13.22M
Enterprise Value$8.91M
Total Cash (Recent Filing)$2.01M
Total Debt (Recent Filing)$3.28M
Price to Earnings (P/E)49.7
Beta0.99
Next Earnings
Sep 16, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.29
Shares Outstanding5,346,823
10 Day Avg. Volume41,844,692
30 Day Avg. Volume14,022,566
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap0.67
Enterprise Value/Revenue20.65
Enterprise Value/Gross Profit-7.95
Enterprise Value/Ebitda-2.87
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Aptorum Group News
APM FAQ
What was Aptorum Group Ltd’s price range in the past 12 months?
Aptorum Group Ltd lowest stock price was $0.46 and its highest was $7.49 in the past 12 months.
What is Aptorum Group Ltd’s market cap?
Aptorum Group Ltd’s market cap is $13.22M.
When is Aptorum Group Ltd’s upcoming earnings report date?
Aptorum Group Ltd’s upcoming earnings report date is Sep 16, 2025 which is in 9 days.
How were Aptorum Group Ltd’s earnings last quarter?
Aptorum Group Ltd released its earnings results on Apr 21, 2025. The company reported -$0.29 earnings per share for the quarter, missing the consensus estimate of N/A by -$0.29.
Is Aptorum Group Ltd overvalued?
According to Wall Street analysts Aptorum Group Ltd’s price is currently Overvalued.
Does Aptorum Group Ltd pay dividends?
Aptorum Group Ltd does not currently pay dividends.
What is Aptorum Group Ltd’s EPS estimate?
Aptorum Group Ltd’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Aptorum Group Ltd have?
Aptorum Group Ltd has 5,346,823 shares outstanding.
What happened to Aptorum Group Ltd’s price movement after its last earnings report?
Aptorum Group Ltd reported an EPS of -$0.29 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 3.614%.
Which hedge fund is a major shareholder of Aptorum Group Ltd?
Currently, no hedge funds are holding shares in APM
Aptorum Group Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Blogger Sentiment
Bullish
APM Sentiment 100%
Sector Average 71%
Sector Average 71%
Crowd Wisdom
Very Positive
Last 7 Days ▼ 4.8%
Last 30 Days ▲ 109.5%
Last 30 Days ▲ 109.5%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-38.33%
12-Months-Change
Fundamentals
Return on Equity
-18.56%
Trailing 12-Months
Asset Growth
-21.85%
Trailing 12-Months
Company Description
Aptorum Group Ltd
Aptorum Group Limited (APM) is a biopharmaceutical company focused on developing and commercializing therapeutic projects to treat unmet medical needs. Based in Hong Kong, Aptorum Group operates across multiple sectors including drug development for infectious diseases, oncology, and other diseases, alongside its healthcare and consumer product businesses. The company emphasizes innovation in its approach to developing small molecule drugs and other therapeutic solutions.
Technical Analysis
Brainstorm Cell Therapeutics
―
GT Biopharma
―
Lyra Therapeutics
―
Conduit Pharmaceuticals
―
Lipella Pharmaceuticals, Inc.
―
Ownership Overview
―
Insiders
0.05% Mutual Funds
0.26% Other Institutional Investors
99.04% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---